Advertisement
Screener

TARSUS PHARMACEUTICALS, INC. (TARS) Gain (Loss) on Termination of Lease

2.6 / 5 stars · 21/41 Roast Me

TARSUS PHARMACEUTICALS, INC. Gain (Loss) on Termination of Lease

TARSUS PHARMACEUTICALS, INC. (TARS) reported Gain (Loss) on Termination of Lease of $0 for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-09.

Discontinued › Income Statement › Other Income

us-gaap:GainLossOnTerminationOfLease · last filed 2022-11-09

  • TARSUS PHARMACEUTICALS, INC. gain (loss) on termination of lease for the quarter ending 2022-03-31 was $0.00.
  • TARSUS PHARMACEUTICALS, INC. gain (loss) on termination of lease for the quarter ending 2021-03-31 was -$2.00K.
  • TARSUS PHARMACEUTICALS, INC. gain (loss) on termination of lease for the quarter ending 2020-03-31 was $0.00.
Period endGain (Loss) on Termination of Lease 3 monthGain (Loss) on Termination of Lease 6 monthGain (Loss) on Termination of Lease 9 month
2022-09-30$0.00
10-Q · filed 2022-11-09
2022-06-30$0.00
10-Q · filed 2022-08-11
2022-03-31$0.00
10-Q · filed 2022-05-11
2021-09-30-$2.00K
10-Q · filed 2022-11-09
2021-06-30-$2.00K
10-Q · filed 2022-08-11
2021-03-31-$2.00K
10-Q · filed 2022-05-11
2020-09-30$0.00
10-Q · filed 2021-11-10
2020-06-30$0.00
10-Q · filed 2021-08-05
2020-03-31$0.00
10-Q · filed 2021-05-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
Denali Therapeutics Inc. (DNLI)United States$3.274B-8.04
Relay Therapeutics, Inc. (RLAY)United States$3.884B-14.30
Beam Therapeutics Inc. (BEAM)United States$2.549B-41.51
Greenland Mines Ltd (GRML)United States$2.362B
BIOCRYST PHARMACEUTICALS INC (BCRX)United States$2.175B-6.63
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Vericel Corp (VCEL)United States$2.011B93.97
Adaptive Biotechnologies Corp (ADPT)United States$4.719B-53.43